InsiderTrades.com logo

MBIO Insider Trading

Insider Ownership Percentage: 4.00%
Insider Buying (Last 12 Months): $237.12
Insider Selling (Last 12 Months): $240.92

Mustang Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Mustang Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mustang Bio Share Price & Price History

Current Price: $0.70
Price Change: ▼ Price Decrease of -0.043 (-5.79%)
As of 04/10/2026 05:00 PM ET

This chart shows the closing price history over time for MBIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Mustang Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/30/2025Adam J ChillDirectorSell4$0.95$3.80375View SEC Filing Icon  
12/30/2025David JinDirectorBuy247$0.96$237.12286View SEC Filing Icon  
12/30/2025Neil HerskowitzDirectorSell247$0.96$237.12145View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Mustang Bio (NASDAQ:MBIO)

9.95% of Mustang Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MBIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Mustang Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2026Kestra Advisory Services LLC111,042$0.11M0.0%+68.0%1.521%Search for SEC Filing on Google Icon
2/12/2026DRW Securities LLC73,936$73K0.0%N/A1.013%Search for SEC Filing on Google Icon
5/28/2025Anson Funds Management LP45,716$57K0.0%N/A1.044%Search for SEC Filing on Google Icon
5/14/2025Anson Funds Management LP45,716$57K0.0%N/A1.383%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC284,437$50K0.0%+15.9%29.629%Search for SEC Filing on Google Icon
8/8/2024Thoroughbred Financial Services LLC53,000$25K0.0%N/A0.423%Search for SEC Filing on Google Icon
8/6/2024Koss Olinger Consulting LLC98,366$47K0.0%N/A0.786%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC30,176$31K0.0%N/A0.290%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC435,764$0.59M0.0%N/A4.726%Search for SEC Filing on Google Icon
7/31/2023Koss Olinger Consulting LLC100,000$0.62M0.1%N/A1.225%Search for SEC Filing on Google Icon
7/27/2023B. Riley Wealth Advisors Inc.10,240$64K0.0%N/A0.125%Search for SEC Filing on Google Icon
5/10/2023Oppenheimer & Co. Inc.91,982$34K0.0%-11.6%1.251%Search for SEC Filing on Google Icon
5/1/2023Arete Wealth Advisors LLC15,538$5.70B0.0%N/A0.211%Search for SEC Filing on Google Icon
2/8/2023Oppenheimer & Co. Inc.104,077$41K0.0%-14.0%0.098%Search for SEC Filing on Google Icon
11/18/2022Spotlight Asset Group Inc.305,312$0.14M0.1%N/A0.288%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC288,934$0.14M0.0%-14.4%0.272%Search for SEC Filing on Google Icon
11/14/2022Oppenheimer & Co. Inc.120,980$57K0.0%+168.9%0.114%Search for SEC Filing on Google Icon
11/7/2022Western Wealth Management LLC90,000$42K0.0%N/A0.085%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP1,445,600$0.85M0.0%N/A1.403%Search for SEC Filing on Google Icon
8/12/2022Ikarian Capital LLC246,824$0.15M0.0%-54.9%0.240%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP1,216,445$1.23M0.2%-7.7%1.213%Search for SEC Filing on Google Icon
5/2/2022National Asset Management Inc.310,926$0.32M0.0%+16.1%0.310%Search for SEC Filing on Google Icon
2/15/2022Sassicaia Capital Advisers LLC15,500$26K0.2%N/A0.017%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP1,318,400$2.19M0.3%+135.3%1.411%Search for SEC Filing on Google Icon
2/9/2022Dimensional Fund Advisors LP927,589$1.54M0.0%-12.3%0.993%Search for SEC Filing on Google Icon
2/8/2022ProShare Advisors LLC28,907$48K0.0%N/A0.031%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp617,969$1.03M0.0%-8.5%0.661%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC19,958$33K0.0%-52.1%0.021%Search for SEC Filing on Google Icon
2/7/2022Arete Wealth Advisors LLC15,538$26K0.0%N/A0.017%Search for SEC Filing on Google Icon
2/4/2022Envestnet Asset Management Inc.42,311$70K0.0%+139.3%0.045%Search for SEC Filing on Google Icon
2/3/2022Los Angeles Capital Management LLC136,876$0.23M0.0%+24.7%0.147%Search for SEC Filing on Google Icon
2/2/2022PVG Asset Management Corp14,870$25K0.1%N/A0.016%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Mustang Bio logo
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-117 and MB-217, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-101 CAR T cell program for glioblastoma; MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.
Read More on Mustang Bio

Today's Range

Now: $0.70
Low: $0.70
High: $0.77

50 Day Range

MA: $0.86
Low: $0.70
High: $1.03

52 Week Range

Now: $0.70
Low: $0.53
High: $7.00

Volume

53,208 shs

Average Volume

34,036 shs

Market Capitalization

$5.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.18

Who are the company insiders with the largest holdings of Mustang Bio?

Mustang Bio's top insider shareholders include:
  1. Manuel Md Litchman (Director)
  2. Adam J Chill (Director)
  3. David Jin (Director)
  4. Neil Herskowitz (Director)
  5. Brian Achenbach (SVP)
  6. Lindsay A Md Rosenwald (Director)
  7. Manuel Md Litchman (CEO)
Learn More about top insider investors at Mustang Bio.

Mustang Bio Active Insiders

Manuel Md Litchman
Manuel Md Litchman (Age 72)
CEO
Brian Achenbach
Brian Achenbach (Age 61)
SVP